,

Some of the principal treatments for osteoporosis could reduce the incidence of COVID-19

Some of the principal treatments for osteoporosis could reduce the incidence of COVID-19 - برخی از داروهای اصلی پوکی استخوان باعث کاهش بروز کووید19 می شود

Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University and the Pere Virgili Health Park. The study, the first of its kind in the world, has just been published the journal Aging.

Release date: 3 November 2020
Source: IMIM (Hospital del Mar Medical Research Institute)

You might also like
Smell and taste changes provide early indication of COVID-19 community spread - تغییرات بویایی و چشایی می تواند نشانه گسترش کرونا در جامعه باشد Smell and taste changes provide early indication of COVID-19 community spread
Covid-19 risk increases with airborne pollen - ریزگردها و خطر انتقال کرونا Covid-19 risk increases with airborne pollen
Statin Use Associated With Increased Survival in Severe COVID19 - داروهای استاتین کاهنده مرگ در بیماران کرونایی Statin Use Associated With Increased Survival in Severe COVID-19
Impact of ACE-i and ARBs for patients with COVID-19 - تاثیر داروهای ضدفشارخون بر کووید19 Impact of ACE-i and ARBs for patients with COVID-19
Immune memory less durable after severe COVID19 - ایمنی کرونایی Immune memory less durable after severe COVID-19
COVID-19 Pneumonia Increases Dementia Risk - دمانس کرونایی COVID-19 Pneumonia Increases Dementia Risk